Mankind Pharma Approves Voluntary Liquidation of Subsidiary Bharat Serums and Vaccines
Mankind Pharma Ltd 路 Others (Uncategorized) 路 07 Sept 2026, 10:42 pm
Mankind Pharma Approves Voluntary Liquidation of Subsidiary Bharat Serums and Vaccines Mankind Pharma announced that members of its wholly owned subsidiary, Bharat Serums and Vaccines Limited (BSVL), approved a proposal for voluntary liquidation during an Extraordinary General Meeting on 7th Sep'26. The move follows preparatory activities initiated on 26th Aug'26. The voluntary liquidation process remains subject to formal approval from BSVL's creditors under the Insolvency and Bankruptcy Code, 2016, and the IBBI Voluntary Liquidation Process Regulations, 2017.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA 路 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference 路 06 Nov 2026
- Please find attached intimation regarding ESG Rating 路 05 Nov 2026
- Intimation of participation in the Investor Conference. 路 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 路 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL 路 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet 路 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 路 27 Oct 2026
